AEON Biopharma News

AEON Biopharma | 8-K: Current report

Jun 14 16:19 ET

AEON Biopharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 31 16:09 ET

AEON Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Sy Jennifer

May 24 20:07 ET

AEON Biopharma | 8-K: Current report

May 16 16:33 ET

AEON Biopharma | 10-Q: Quarterly report

May 14 16:46 ET

AEON Biopharma | 8-K: AEON Biopharma Reports First Quarter 2024 Financial Results

May 14 16:11 ET

AEON Biopharma | ARS/A: Others

May 14 09:19 ET

AEON Biopharma | DEFA14A: Others

May 14 09:19 ET

AEON Biopharma | 10-K/A: Annual report (Amendment)

May 14 09:09 ET

AEON Biopharma | 8-K: Current report

May 3 16:32 ET

AEON Biopharma | 8-K: Current report

May 3 07:06 ET

AEON Biopharma | ARS: Annual Report to Security Holders

Apr 29 17:04 ET

AEON Biopharma | DEF 14A: Definitive information statements

Apr 29 16:59 ET

AEON Biopharma | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Apr 29 16:24 ET

AEON Biopharma | 3: Initial statement of beneficial ownership of securities-Director Park Seongsoo

Apr 18 18:27 ET

AEON Biopharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 17 16:17 ET

AEON Biopharma | 8-K: Current report

Apr 17 16:11 ET

AEON Biopharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Daewoong Co., Ltd

Apr 16 21:11 ET

AEON Biopharma | 8-K: Current report

Apr 15 16:21 ET

AEON Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Daewoong Co., Ltd

Apr 12 07:07 ET